We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.55B
AUM Growth
+$133M
Cap. Flow
+$228M
Cap. Flow %
6.44%
Top 10 Hldgs %
31.71%
Holding
123
New
40
Increased
24
Reduced
23
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$71.8M
2
ABBV icon
AbbVie
ABBV
+$63.8M
3
CI icon
Cigna
CI
+$62.3M
4
PBYI icon
Puma Biotechnology
PBYI
+$49.5M
5
UNH icon
UnitedHealth
UNH
+$44.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$99.2M
2
META icon
Meta Platforms (Facebook)
META
+$73.1M
3
BAX icon
Baxter International
BAX
+$70M
4
NOW icon
ServiceNow
NOW
+$67.7M
5
V icon
Visa
V
+$65.5M

Sector Composition

Rank Sector Weight
1 Healthcare 40.7%
2 Technology 6.07%
3 Energy 6.01%
4 Industrials 3.89%
5 Communication Services 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXGN
76
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$9.82M 0.28%
+746,431
New +$9.56M
RGNX icon
77
Regenxbio
RGNX
$615M
$9.25M 0.26%
498,585
+211,346
+74% +$4.04M
NOVN
78
DELISTED
Novan, Inc. Common Stock
NOVN
$9.23M 0.26%
34,163
-7,638
-18% -$1.76M
ELGX
79
DELISTED
Endologix Inc
ELGX
$6.27M 0.18%
109,651
+56,081
+105% +$5.14M
MOH icon
80
CALL
Molina Healthcare
MOH
$10.5B
$5.43M 0.15%
+100,000
New +$5.47M
DY icon
81
Dycom Industries
DY
$12.1B
$5.38M 0.15%
+66,976
New +$5.42M
TMUS icon
82
T-Mobile US
TMUS
$196B
$5.37M 0.15%
93,378
-324,738
-78% -$17M
WERN icon
83
Werner Enterprises
WERN
$2.3B
$5.1M 0.14%
+189,358
New +$4.88M
JUNO
84
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.26M 0.06%
119,668
-1,004,617
-89% -$24.6M
IVTY
85
DELISTED
Invuity, Inc
IVTY
$1.33M 0.04%
+231,329
New +$1.94M
ISEE
86
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$548K 0.02%
+113,382
New +$3.37M
AAPL icon
87
Apple
AAPL
$4.99T
-3,509,392
Closed -$99.2M
AMZN icon
88
Amazon
AMZN
$2.48T
-1,199,960
Closed -$50.2M
BABA icon
89
Alibaba
BABA
$276B
-240,069
Closed -$25.4M
BAX icon
90
Baxter International
BAX
$12.6B
-1,469,562
Closed -$70M
BKD icon
91
Brookdale Senior Living
BKD
$3.67B
-2,539,208
Closed -$44.3M
BMY icon
92
PUT
Bristol-Myers Squibb
BMY
$130B
-1,124,700
Closed -$60.6M
CCK icon
93
Crown Holdings
CCK
$13.2B
-560,246
Closed -$32M
CMG icon
94
Chipotle Mexican Grill
CMG
$43B
-4,604,950
Closed -$39M
CNC icon
95
Centene
CNC
$31.6B
-407,514
Closed -$13.6M
GRPN icon
96
Groupon
GRPN
$1.07B
-97,196
Closed -$10M
HCA icon
97
HCA Healthcare
HCA
$92.8B
-277,352
Closed -$21M
HD icon
98
Home Depot
HD
$343B
-394,779
Closed -$50.8M
HLF icon
99
Herbalife
HLF
$1.3B
-1,293,950
Closed -$40.1M
HOUS
100
DELISTED
Anywhere Real Estate
HOUS
-454,543
Closed -$11.8M

Similar funds

PFM Health Sciences's Q4 2016 Portfolio in Review

As of Q4 2016, PFM Health Sciences held 123 positions worth $3.55B, up 3.9% from $3.42B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences deployed $228M of net new capital in Q4 2016, opening 40 new positions and adding to 24 existing holdings. Its largest new stake was Elevance Health: 536,457 shares worth $77.1M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $73.1M trimmed.

  • PFM Health Sciences's largest Q4 2016 buy was Elevance Health: 536,457 shares worth $77.1M.
  • PFM Health Sciences added most to AbbVie in Q4 2016, an estimated $63.8M increase.
  • PFM Health Sciences's biggest Q4 2016 reduction was Meta Platforms (Facebook), cutting an estimated $73.1M.
  • PFM Health Sciences fully exited Apple in Q4 2016, selling an estimated $99.2M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.55B portfolio in Q4 2016.
  • PFM Health Sciences opened 40 new positions and closed 30 in Q4 2016.
  • PFM Health Sciences's portfolio value rose 3.9% quarter-over-quarter to $3.55B.

Based on PFM Health Sciences's 13F filing for Q4 2016, filed 14 Feb 2017.